Tokyo, Japan

Kagari Fujita


Average Co-Inventor Count = 10.3

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Tsukuba, JP (1996)
  • Tokyo, JP (1992 - 1997)

Company Filing History:


Years Active: 1992-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kagari Fujita: Innovator in Endothelin Antagonistic Peptides

Introduction

Kagari Fujita is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of endothelin antagonistic peptides. With a total of 6 patents to his name, Fujita's work has the potential to impact various medical conditions.

Latest Patents

Fujita's latest patents include innovative compounds that serve as antagonists of endothelin. One notable invention relates to endothelin antagonistic peptide derivatives, which are useful in treating conditions such as hypertension, pulmonary hypertension, and myocardial infarction. These compounds are designed to inhibit the binding of endothelin to its ETB receptor, providing therapeutic benefits for diseases associated with excess endothelin production.

Career Highlights

Fujita is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in treating serious health issues, including acute renal failure and asthma.

Collaborations

Fujita has collaborated with notable colleagues such as Kiyofumi Ishikawa and Takehiro Fukami. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Kagari Fujita's contributions to the field of pharmaceuticals through his patents on endothelin antagonistic peptides highlight his role as a key innovator. His work not only showcases his dedication to medical advancements but also promises to improve the quality of life for many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…